nHance™ PCS, Biosimilars and Comparison to SPE

April 16, 2018

In a recent study, we used nHance PCS to develop a method for Exendin 9-39. The method not only exceeded FDA requirements on accuracy and precision, but also took only 45 minutes to run the workflow with a method development time of 4-5 FTE.
We also embarked on a direct comparison with SPE. Here, in comparison to a manufacturer published literature method, nHance PCS took half the time to run the workflow, provided more effective matrix interference reduction and required minimal pretreatment while providing accuracy, precision and recovery values equivalent to SPE method.

Please reload


NanoMedical Systems
2101 E. St. Elmo, Bldg. 1

Austin, TX 78744



©2018 by nHance PCS. Proudly created with Wix.com